MicroRNAs (miRNAs), the newly discovered regulators of gene expression, act by promoting degradation of mRNA and/or by inhibiting protein expression. Dysregulation of miRNA expression has been noted in an expanding number of diseases; and in some instances, manipulating miRNA expression holds promise as a new form of therapy. Herpetic stromal keratitis (HSK) is an important vision-impairing lesion and currently any role that miRNA dysregulation plays during its pathogenesis is only just beginning to be investigated. In this review, we discuss the likely participation of specific miRNAs during HSK and discuss the prospect of modulating their expression as a means of therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558297 | PMC |
| http://dx.doi.org/10.1167/iovs.12-11094 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Therapeutic Efficacy of Adipose Tissue-Derived Components in Neuropathic Pain: A Systematic Review.
Bioengineering (Basel)
September 2024
Department of Plastic, Reconstructive and Hand Surgery, University Medical Center Utrecht (UMC Utrecht), 3584 CX Utrecht, The Netherlands.
Background: Neuropathic pain results from a defect in the somatosensory nervous system caused by a diversity of etiologies. The effect of current treat-ment with analgesics and surgery is limited. Studies report the therapeutic use of adipose tissue-derived components to treat neuropathic pain as a new treatment modality.
View Article and Find Full Text PDFTrigeminal Trophic Syndrome With Herpetic Keratitis.
Cornea
February 2025
John F. Hardesty Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO.
Article Synopsis
- This study reports a unique case of trigeminal trophic syndrome occurring alongside herpetic keratitis in a 42-year-old male with a history of severe facial injuries and nerve damage.
- The patient was found to have significant facial sensitivity loss and corneal issues linked to herpes, leading to a diagnosis of herpetic keratitis and ulceration due to trigeminal trophic syndrome.
- Treatment involved antibiotics, antiviral medication, and topical steroids, resulting in improved vision and the use of a custom facial mask to prevent self-harm.
Outcomes of Corneal Transplantation for Herpetic Keratitis: A Narrative Review.
Viruses
August 2024
Research Department, King Khaled Eye Specialist Hospital, Riyadh 12329, Saudi Arabia.
Herpes simplex virus (HSV) is one of the most common etiologic agents of corneal disease and a significant cause of corneal blindness worldwide. Although most cases can be successfully managed with medical therapy, HSV keratitis associated with visually significant stromal scarring often requires corneal transplantation for visual rehabilitation. While penetrating keratoplasty (PK) represented the traditional keratoplasty technique, the past few decades have seen a shift towards lamellar keratoplasty procedures, including deep anterior lamellar keratoplasty and mushroom keratoplasty.
View Article and Find Full Text PDFPresence of CD80 and Absence of LAT in Modulating Cellular Infiltration and HSV-1 Latency.
Viruses
August 2024
Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, Cedars-Sinai Burns & Allen Research Institute, CSMC - SSB3, 8700 Beverly Blvd., Los Angeles, CA 90048, USA.
CD80 is the best-known costimulatory molecule for effective T cell functions. Many different reports have summarized the role of CD80 in HSV-1 and its functions in maintaining adaptive immunity, which is the main player in causing herpes stromal keratitis (HSK). To determine the effects of absence or overexpression of CD80 in HSV-1 infection, we infected CD80 and WT mice with a recombinant HSV-1 expressing murine CD80 (HSV-CD80) in place of the latency associated transcript (LAT).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!